News, Money and Drugs for Wednesday, June 24, 2009
June 24, 2009 at 8:57 pm EST | Tags: News
Watson Pharmaceuticals has received FDA approval to sell the first generic copy of Plan B, the emergency contraceptive made by Teva Pharmaceutical Industries. [Bloomberg]
Faes Farma and Pfizer? [Pharmalive]
FDA rejects GSK’s anti-nausea drug, Resonic (casopitant mesylate). [FierceBiotech]
Perfect timing! On the brink of bankruptcy, Protein Sciences gets $35M government contract for flu vaccine. [New York Times]
Gardasil for boys not so effective. [Bloomberg]
No side effects with Ista Pharmaceuticals’ Bepreve. [AP]
Vertex CEO speaks! [BizJournals]
Finally, the FTC says that eliminating patent settlements between brand-name and generic drug companies will save consumers $3.5 billion!!! What about patent lawyers???!!! Oh, they would be PO’ed for sure… [BNET Pharma]
Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com



